IMMUDEX ApS — Credit Rating and Financial Key Figures
CVR number: 31348854
Bredevej 2 A, 2830 Virum
pd@immudex.com
tel: 31109191
www.immudex.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 15 279.64 | 24 389.36 | 18 937.90 | 29 872.20 | 25 173.10 |
| Employee benefit expenses | -17 002.43 | -22 615.63 | -27 971.48 | -29 836.12 | -33 091.03 |
| Total depreciation | - 537.39 | -1 075.71 | -1 475.86 | -1 524.96 | -1 693.58 |
| EBIT | -2 260.17 | 698.03 | -10 509.43 | -1 488.88 | -9 611.52 |
| Other financial income | 659.00 | 413.32 | 2 191.59 | 739.79 | 1 063.46 |
| Other financial expenses | - 710.22 | -1 012.05 | - 260.32 | -1 033.40 | - 436.72 |
| Reduction non-current investment assets | 107.69 | -50.57 | - 608.49 | 414.85 | - 113.16 |
| Pre-tax profit | -2 203.70 | 48.73 | -9 186.66 | -1 367.65 | -9 097.94 |
| Income taxes | 532.29 | 705.73 | 2 418.06 | 275.57 | 1 992.06 |
| Net earnings | -1 671.41 | 754.45 | -6 768.59 | -1 092.08 | -7 105.88 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 2 831.68 | 6 751.64 | |||
| Intangible rights | 1 012.87 | 1 078.66 | 602.40 | 170.63 | |
| Intangible assets total | 1 012.87 | 1 078.66 | 3 434.07 | 6 922.27 | |
| Buildings | 3 422.22 | 3 188.89 | 2 955.56 | 2 750.27 | 2 510.70 |
| Machinery and equipment | 2 109.76 | 2 777.57 | 2 022.21 | 1 422.52 | 915.35 |
| Tangible assets total | 5 531.98 | 5 966.46 | 4 977.77 | 4 172.80 | 3 426.05 |
| Investments total | 480.41 | 461.29 | 473.27 | 522.06 | 524.72 |
| Long term receivables total | |||||
| Semifinished products | 7 673.90 | 7 805.67 | 7 735.42 | 8 761.33 | 9 315.87 |
| Inventories total | 7 673.90 | 7 805.67 | 7 735.42 | 8 761.33 | 9 315.87 |
| Current trade debtors | 1 665.29 | 2 918.86 | 4 751.92 | 3 752.62 | 2 733.23 |
| Current amounts owed by group member comp. | 4 423.95 | 6 760.99 | 10 031.96 | 8 693.91 | 8 270.18 |
| Prepayments and accrued income | 738.82 | 724.31 | 41.94 | 1 339.63 | 1 085.14 |
| Current other receivables | 12 711.02 | 729.36 | 1 743.36 | 1 505.62 | 2 000.25 |
| Current deferred tax assets | 4 933.69 | 5 194.99 | 4 351.41 | 4 626.98 | 5 951.09 |
| Short term receivables total | 24 472.77 | 16 328.51 | 20 920.59 | 19 918.76 | 20 039.88 |
| Cash and bank deposits | 7 804.37 | 15 265.73 | 5 874.56 | 5 640.37 | 6 358.53 |
| Cash and cash equivalents | 7 804.37 | 15 265.73 | 5 874.56 | 5 640.37 | 6 358.53 |
| Balance sheet total (assets) | 45 963.43 | 46 840.55 | 41 060.27 | 42 449.38 | 46 587.33 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 688.67 | 688.67 | 700.14 | 711.51 | 725.93 |
| Other reserves | 2 208.71 | 3 765.07 | |||
| Retained earnings | 34 679.71 | 33 008.30 | 35 444.11 | 28 096.00 | 27 561.83 |
| Profit of the financial year | -1 671.41 | 754.45 | -6 768.59 | -1 092.08 | -7 105.88 |
| Shareholders equity total | 33 696.97 | 34 451.42 | 29 375.65 | 29 924.14 | 24 946.95 |
| Non-current deferred tax liabilities | 3 250.27 | 4 623.56 | 4 433.30 | 4 359.87 | 4 049.49 |
| Non-current liabilities total | 3 250.27 | 4 623.56 | 4 433.30 | 4 359.87 | 4 049.49 |
| Current loans from credit institutions | 187.90 | 205.95 | 337.03 | 327.21 | 342.32 |
| Advances received | 165.92 | 198.50 | 297.26 | ||
| Current trade creditors | 2 643.76 | 2 529.91 | 3 052.30 | 5 235.42 | 3 597.89 |
| Current owed to group member | 294.39 | 10 704.30 | |||
| Other non-interest bearing current liabilities | 5 890.14 | 5 029.70 | 3 696.07 | 2 404.23 | 2 649.13 |
| Current liabilities total | 9 016.20 | 7 765.56 | 7 251.31 | 8 165.37 | 17 590.89 |
| Balance sheet total (liabilities) | 45 963.43 | 46 840.55 | 41 060.27 | 42 449.38 | 46 587.33 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.